Clinical Trials Directory

Trials / Unknown

UnknownNCT03401424

Comparison of Two Kinds of Biliary Intestinal Reconstruction in Cholangiectasia

The RCT Study of Two Surgical Biliary-enteric Reconstruction Minimally Invasive Treatment of Bile Duct Dilatation

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Southwest Hospital, China · Academic / Other
Sex
All
Age
5 Years – 70 Years
Healthy volunteers
Not accepted

Summary

To observe and compare the short-term and long-term effects of different biliary and intestinal reconstruction methods for the treatment of congenital cystic dilatation of bile duct .

Detailed description

The purpose of the study: length of operation time, postoperative intestinal function recovery time as the main index, application prospective clinical study to observe the differences were followed by two different laparoscopic biliary intestinal kiss the short-term and long-term effect of the treatment of congenital cystic dilatation of the bile duct, provide a higher level of evidence based medicine dilatation of patients for congenital bile duct cysts. The choice of second is based on the study, effective, objective evaluation of different laparoscopic biliary enteric reconstruction for the treatment of congenital cystic dilatation of the bile duct is feasible, clear surgical indications, contraindications and summarized the technical points, establish guidelines for clinical diagnosis and treatment of congenital cystic dilation of the bile duct disease.

Conditions

Interventions

TypeNameDescription
PROCEDUREimproved Warren-type styleSelect 60 cases of biliary dilatation in patients undergoing laparoscopic cyst excision plus modified Warren cholangiobiliary reconstruction.
PROCEDURERoux-en-Y styleSelect 60 cases of biliary dilatation in patients undergoing laparoscopic cyst excision Roux-en-Y cholangiobiliary reconstruction.

Timeline

Start date
2017-06-01
Primary completion
2019-06-01
Completion
2020-06-01
First posted
2018-01-17
Last updated
2018-01-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03401424. Inclusion in this directory is not an endorsement.